Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Digital pharma marketing: 5 ways to avoid localisation problems

Localisation of digital materials isn’t difficult but it can go wrong. Here’s how to keep everything on track.

Anthill Agency

- PMLiVE

Vertex’s Orkambi receives EU green light for licence extension

Becomes first medicine to treat the underlying cause of CF in children

Roche and GE Healthcare plan ‘industry first’ digital platform

Co-developed clinical decision support software will begin with cancer and critical care

- PMLiVE

Celebrating a magical year at the Lucid Winter Meeting

In the frosty sunlight of a winter morning, employees from across the Lucid Group gathered to celebrate a magical year of success at the Lucid Annual Winter Meeting. Traditionally being...

Lucid Group Communications Limited

Celebrating a magical year at the Lucid Winter Meeting

Lucid Group Communications Limited

- PMLiVE

Ipsen appoints Aidan Murphy as EVP, technical operations

He is promoted from senior VP biologics development and manufacturing

- PMLiVE

Taiho Oncology names Timothy Whitten as president

He will assume responsibility of the firm’s corporate and commercial functions

Lilly signs real-world digital diabetes deal with Livongo

Will work with the US consumer digital health firm on research collaboration

- PMLiVE

Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown

The head-to-head trials will evaluate findings in patients with PsA and AS

- PMLiVE

Celixir cleared to start trial of stem cell therapy for heart failure

Previous trial demonstrated patients achieving 100% MACE free survival

- PMLiVE

Duchenne UK and pharma partner pilot data-sharing HTA approach

Pfizer, Roche and PTC Therapeutics are among those participating in Project Hercules

- PMLiVE

Takeda ties-up with Denali Therapeutics for neuroscience boost

The companies will develop new therapies for conditions such as Alzheimer’s

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links